Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
84.49
+1.39 (1.67%)
Jan 15, 2026, 4:00 PM EST - Market closed
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $49.03 billion as of January 16, 2026. Its market cap has increased by 11.97% in one year.
Market Cap
49.03B
Enterprise Value
45.88B
1-Year Change
11.97%
Ranking
Category
Stock Price
$84.49
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $49.03B, an increase of 5,015.24%. That is a compound annual growth rate of 16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 49.00B | -0.89% |
| Dec 31, 2025 | 49.45B | 13.24% |
| Dec 31, 2024 | 43.66B | -5.51% |
| Dec 29, 2023 | 46.21B | 0.17% |
| Dec 30, 2022 | 46.13B | -42.97% |
| Dec 31, 2021 | 80.88B | 42.25% |
| Dec 31, 2020 | 56.86B | 16.86% |
| Dec 31, 2019 | 48.66B | 51.96% |
| Dec 31, 2018 | 32.02B | 34.25% |
| Dec 29, 2017 | 23.85B | 19.05% |
| Dec 30, 2016 | 20.03B | 17.59% |
| Dec 31, 2015 | 17.04B | 25.03% |
| Dec 31, 2014 | 13.63B | 89.40% |
| Dec 31, 2013 | 7.19B | -30.86% |
| Dec 31, 2012 | 10.41B | 29.03% |
| Dec 30, 2011 | 8.06B | -12.62% |
| Dec 31, 2010 | 9.23B | 87.85% |
| Dec 31, 2009 | 4.91B | 60.64% |
| Dec 31, 2008 | 3.06B | 17.27% |
| Dec 31, 2007 | 2.61B | -4.23% |
| Dec 29, 2006 | 2.72B | 10.05% |
| Dec 30, 2005 | 2.47B | 0.91% |
| Dec 31, 2004 | 2.45B | 37.56% |
| Dec 31, 2003 | 1.78B | 16.52% |
| Dec 31, 2002 | 1.53B | -6.49% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |